SCHEMBL983664

SCHEMBL983664

CC(NC(=O)CN1CCNCC1)C(C)(C)C

nearest known ligand 0.71

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.71
CHRM3 P20309 2/20 0.71
SIGMAR1 Q99720 7/20 0.61
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP2C9 P11712 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899461 0.85 SIGMAR1 (0.75) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL255190 0.83 CHRM5 (1.00) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL1547058 0.76 SIGMAR1 (0.63) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL20946422 0.76 SIGMAR1 (0.63) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL1021537 0.76 SIGMAR1 (1.00) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL9573732 0.76 CHRM5 (0.58) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL2007992 0.75 CHRM5 (0.67) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
Hydrochloric Acid SCHEMBL26129894 0.75 SIGMAR1 (0.61) CHRM5CHRM3SIGMAR1ALDH1A1NPC1
SCHEMBL19640159 0.75 SIGMAR1 (0.61) CHRM5CHRM3SIGMAR1ALDH1A1GAA
Hydrochloric Acid SCHEMBL2009825 0.75 SIGMAR1 (0.61) CHRM5CHRM3SIGMAR1ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed